
News|Articles|January 16, 2024
Prefabricated Modular Construction: The Good, the Bad, and the Not So Obvious Benefits
Author(s)G-CON
Prefabricated modular construction has gained momentum in many industries around the globe. However, traditionalists continue to have concern and resist adoption of this approach.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5